Ingelheim am Rhein, Germany

Otto Kern

This inventor holds 4 USPTO granted patents. Top assignees: Boehringer Ingelheim Vetmedica Gmbh, Boehringer Ingelheim Gmbh. Active years: 1986-1997.


% Patents Active = 100.0

Average Co-Inventor Count = 2.9

ph-index = 3

Forward Citations = 49(Granted Patents)


Company Filing History:


Years Active: 1986-1997

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Otto Kern: Innovator in Biodegradable Systems

Introduction

Otto Kern is a notable inventor based in Ingelheim am Rhein, Germany. He has made significant contributions to the field of biodegradable systems, holding a total of 4 patents. His work focuses on innovative solutions for releasing active substances in medical applications.

Latest Patents

Kern's latest patents include an implantable, biodegradable system for releasing active substances. This invention addresses the need for effective delivery mechanisms in medical treatments. Another significant patent involves a method of improving the absorption of injected antibacterial substances. This method enhances the effectiveness of antibacterial agents administered parenterally, utilizing a benzylamine derivative to optimize absorbability.

Career Highlights

Throughout his career, Otto Kern has worked with prominent companies such as Boehringer Ingelheim Vetmedica GmbH and Boehringer Ingelheim GmbH. His experience in these organizations has allowed him to develop and refine his innovative ideas in the field of biotechnology.

Collaborations

Kern has collaborated with notable colleagues, including Franz Wilhelm and Ernst Salamon. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Otto Kern's contributions to the field of biodegradable systems and antibacterial substance absorption highlight his role as an influential inventor. His work continues to impact medical technology and improve treatment efficacy.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…